MYCN and neuroblastoma: In this aberrant cell state, overexpression of MYCN (mimicking MYCN amplification commonly found along with chr17q/chr1q gains in NB tumours) leads to a complete derailment of sympathoadrenal lineage specification, and a proliferative, tumour-like cellular phenotype that correlates with the emergence of NB-like tumours in vivo.